000661 Stock Overview
Researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 6/6 |
Rewards
Risk Analysis
No risks detected for 000661 from our risk checks.
Changchun High-Tech Industry (Group) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥79.39 |
| 52 Week High | CN¥165.73 |
| 52 Week Low | CN¥78.60 |
| Beta | 0.38 |
| 11 Month Change | -15.00% |
| 3 Month Change | -23.44% |
| 1 Year Change | -41.61% |
| 33 Year Change | -67.69% |
| 5 Year Change | -56.55% |
| Change since IPO | 4,257.43% |
Recent News & Updates
Changchun High-Tech Industry (Group) Co., Ltd. Just Missed Revenue By 11%: Here's What Analysts Think Will Happen Next
Aug 18
Improved Earnings Required Before Changchun High-Tech Industry (Group) Co., Ltd. (SZSE:000661) Shares Find Their Feet
Aug 15Recent updates
Changchun High-Tech Industry (Group) Co., Ltd. Just Missed Revenue By 11%: Here's What Analysts Think Will Happen Next
Aug 18Improved Earnings Required Before Changchun High-Tech Industry (Group) Co., Ltd. (SZSE:000661) Shares Find Their Feet
Aug 15Changchun High-Tech Industry (Group) (SZSE:000661) Seems To Use Debt Rather Sparingly
Jun 12Changchun High-Tech Industry (Group) Co., Ltd. (SZSE:000661) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Apr 23Benign Growth For Changchun High-Tech Industries (Group) Inc. (SZSE:000661) Underpins Its Share Price
Apr 12Earnings Miss: Changchun High-Tech Industries (Group) Inc. Missed EPS By 6.6% And Analysts Are Revising Their Forecasts
Mar 22Shareholder Returns
| 000661 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.6% | -1.7% | -2.4% |
| 1Y | -41.6% | -10.7% | -20.1% |
Return vs Industry: 000661 underperformed the CN Pharmaceuticals industry which returned -10.7% over the past year.
Return vs Market: 000661 underperformed the CN Market which returned -20.1% over the past year.
Price Volatility
| 000661 volatility | |
|---|---|
| 000661 Average Weekly Movement | 4.0% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 8.7% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 000661's share price has been volatile over the past 3 months.
Volatility Over Time: 000661's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 9,029 | Yuntao Jiang | ccht.jl.cn |
Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers genetic engineering pharmaceuticals, biological vaccines, modern Chinese medicines, and other pharmaceutical products; and antibody and other chemical drugs. It also develops real estate properties.
Changchun High-Tech Industry (Group) Co., Ltd. Fundamentals Summary
| 000661 fundamental statistics | |
|---|---|
| Market cap | CN¥31.92b |
| Earnings (TTM) | CN¥4.09b |
| Revenue (TTM) | CN¥15.04b |
7.8x
P/E Ratio2.1x
P/S RatioIs 000661 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000661 income statement (TTM) | |
|---|---|
| Revenue | CN¥15.04b |
| Cost of Revenue | CN¥2.43b |
| Gross Profit | CN¥12.61b |
| Other Expenses | CN¥8.52b |
| Earnings | CN¥4.09b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 10.18 |
| Gross Margin | 83.84% |
| Net Profit Margin | 27.21% |
| Debt/Equity Ratio | 5.9% |
How did 000661 perform over the long term?
See historical performance and comparison